Subscribe
About us
Advertise with us

NeuroSens

Menu

Skip to content

Home
Neurology
Psychiatry

Topic: LGS

Clobazam in Lennox-Gastaut syndrome: phase III results

August 29, 2012

Browse by Topic

MS (336)
AD (82)
PD (78)
COVID-19 (58)
PREVIOUS CONGRESSES (37)
DEPRESSION (36)
MIGRAINE (26)

SCHIZOPHRENIA (25)
STROKE (22)
EPILEPSY (22)
BIOMARKERS IN MS (15)
ECTRIMS 2015 (13)
Library (13)
AAN 2015 (11)
ECTRIMS 2014 (10)
ECTRIMS 2021 (10)
DEMENTIA (10)
ECTRIMS 2019 (10)
CLINICAL CASES IN MS (9)
AAN 2014 (9)
MS SEQUENCING (9)
ECTRIMS 2013 (9)
ECTRIMS 2018 (9)
AAN 2013 (9)
PSYCHIATRY (8)
ACTRIMS-ECTRIMS 2020 (7)
AAN 2019 (7)
ECTRIMS 2017 (6)
ECTRIMS 2022 (6)
AAN 2021 (6)
CHARCOT 2013 (6)
AAN 2022 (5)
BIPOLAR (5)
ECTRIMS 2016 (5)
ANXIETY (5)
CCSVI (5)
EAN 2015 (4)
NeuroSound (4)
BPD (4)
ENS 2013 (3)
AAN 2017 (3)
AAN 2020 (3)
EAN 2022 (3)
PAIN (3)
EAN 2020 (2)
NEW DRUGS (2)
SLEEP (2)
AAN 2018 (2)
SPECIAL REPORT (2)
APA 2014 (2)
ACTRIMS 2022 (1)
LUMBAR PUNCTURE (1)
EAN 2021 (1)
WEST NILE (1)
INSOMNIA (1)
GUIDELINES (1)
TSC (1)
AAN 2016 (1)
APA 2016 (1)
SEIZURE (1)
hATTR (1)
Dravet syndrome (1)
CIDP (1)
CONCUSSION (1)
ADDICTION (1)
ALS (1)
EAN 2019 (1)
LGS (1)
ACTRIMS 2023 (1)
EAN 2016 (0)
ECTRIMS 2020 (0)
BIOMARKERS (0)

View all Topics

Popular Posts

CLINICAL CASES IN MS – A YOUNG WOMAN WITH BREAKTHROUGH DISEASE ON FINGOLIMOD posted on February 22, 2023
CNS effects of Wegovy (semaglutide) posted on February 28, 2023
Proton pump inhibitors linked to neurological conditions posted on November 29, 2019

Copyright 2023 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)

Contact Us Terms and Conditions